Equity · Healthcare
GRDN
NYSEGuardian Pharmacy Services (GRDN)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Revenue, year to Dec 2025
- 1.4B USD
Have Guardian Pharmacy Services (GRDN) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, no Guardian Pharmacy Services insider bought or sold shares on the open market; all 16 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 10 Nov 2026, newest Form 4 filing 27 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 27 Sep 2026 | Mudd William FranklinSee Remarks | Option exercise | 38,282 | |
| 27 Sep 2026 | Weir RobertSee Remarks | Option exercise | 23,450 | |
| 27 Sep 2026 | Ackerman JohnDirector | Option exercise | 1,884,996 | |
| 27 Sep 2026 | Salentine Thomas J JrDirector | Option exercise | 6,100,175 | |
| 27 Sep 2026 | Martin David NormanSee Remarks | Option exercise | 39,865 | |
| 27 Sep 2026 | Pharmacy Investors, LLC | Option exercise | 1,413,939 | |
| 27 Sep 2026 | Burke FredSee Remarks | Option exercise | 1,298,825 | |
| 27 Sep 2026 | Tuch JeffreySee Remarks | Option exercise | 55,578 | |
| 27 Sep 2026 | Forbes Kendall | Option exercise | 608,570 | |
| 27 Sep 2026 | BINDLEY WILLIAM EDirector | Option exercise | 6,100,175 | |
| 27 Sep 2026 | Morris David KSee Remarks | Option exercise | 641,870 | |
| 27 Sep 2026 | Crisafulli ChrisSee Remarks | Option exercise | 18,931 |
Showing the 12 most recent of 16 compensation filings in this window. The figures above count all of them.
Which funds hold Guardian Pharmacy Services (GRDN)?
7 of the 45 institutional funds we track reported a Guardian Pharmacy Services position for the quarter ended 30 Jun 2026 — a combined 19.6M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Millennium Management | Added | 120,607 | 5.0M USD | +343.5% |
| Two Sigma Investments | Trimmed | 98,209 | 4.1M USD | −68.6% |
| Citadel Advisors | Trimmed | 87,775 | 3.7M USD | −84.8% |
| D. E. Shaw & Co. | Held (±25%) | 73,841 | 3.1M USD | −2.4% |
| Renaissance Technologies | Trimmed | 44,798 | 1.9M USD | −55.2% |
| Marshall Wace | Trimmed | 35,996 | 1.5M USD | −91.4% |
| AQR Capital Management | Trimmed | 6,189 | 259K USD | −52.5% |
What has been filed or recorded for Guardian Pharmacy Services (GRDN)?
The filings we hold for Guardian Pharmacy Services, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.29 USD | Revenue $371M |
| 30 Sep 2026 | Financials | Total assets | 491.8M USD | at period end |
| 30 Sep 2026 | Financials | Total equity incl. minority interest | 279.7M USD | at period end |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 5 shares | 204 USD notional |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | Revenue $352M | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | Revenue $337M | |
| 31 Dec 2025 | Annual report | FY 2025 reported | Revenue $1.45B | |
| 31 Dec 2025 | Financials | Revenue | 1.4B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 49.2M USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2026 reported | EPS 0.15 USD | Revenue $377M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | Revenue $344M | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | Revenue $329M | |
| 31 Dec 2024 | Annual report | FY 2025 reported | Revenue $1.23B |
What do people ask about Guardian Pharmacy Services (GRDN)?
What is Guardian Pharmacy Services’ revenue?1.4B
Guardian Pharmacy Services reported revenue of 1.4B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Guardian Pharmacy Services insiders bought or sold shares recently?16 filings
In the 90 days to 10 Nov 2026, no Guardian Pharmacy Services insider bought or sold shares on the open market; all 16 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Guardian Pharmacy Services?7 of 45
7 of the 45 funds we track reported a Guardian Pharmacy Services position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Two Sigma Investments and Citadel Advisors. See Funds
When did Guardian Pharmacy Services last report earnings?0.29
Guardian Pharmacy Services last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.29 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates